Topics

TetraGenetics Appoints Alison Taunton-Rigby, Ellen Baron and Daniel Grau to its Board of Directors

09:00 EDT 2 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Biopharma and Investment Executives with Deep Industry Experience to Support Continued Growth of TetraGenetics Ion Channel Pipeline and Platform TetraGenetics, a biopharmaceutical company developing novel antibody the...

Other Sources for this Article

Suzanne Gibbons-Neff
Suzanne@sgnpr.com
203-858-1325

NEXT ARTICLE

More From BioPortfolio on "TetraGenetics Appoints Alison Taunton-Rigby, Ellen Baron and Daniel Grau to its Board of Directors"

Quick Search

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...